Rytary ER 36.25 MG-145 MG cap 100S
Ended Awarded
- Contract number
- SPE2DB25FMWCX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,500
Award facts
- Contract value 100% obligated
- $5,499.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Rytary ER (carbidopa/levodopa extended-release) 36.25 mg-145 mg capsules in a quantity of 100 units, valued at $5,499.64. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. Rytary ER is a neurological treatment used in Parkinson's disease management, representing the company's ongoing role as a critical pharmaceutical supplier for federal military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that serves as the company's comprehensive global pharmaceutical support mechanism. Through this IDC, AmerisourceBergen supplies an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, branded and generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains. The parent IDC enables the company to serve federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a major vendor within the DLA's pharmaceutical procurement infrastructure.
Quick answers
Who was awarded contract SPE2DB25FMWCX?
SPE2DB25FMWCX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FMWCX worth?
The government has obligated $5,500 on SPE2DB25FMWCX.
Is contract SPE2DB25FMWCX an order under another contract?
Yes. SPE2DB25FMWCX is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMWCX competed?
The extent of competition for SPE2DB25FMWCX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award